Supported by the National Institute on Drug Abuse (NIDA) from the National Institutes of Health (NIH) and sponsored by the Society of Teachers of Family Medicine
The 2016 Call for Applications has closed.
Accelerating the dissemination of substance use disorders (SUD) research findings and encouraging the implementation of evidence-based practices in health care settings is a priority for NIDA and represents the core mission of the NIDA Blending Initiative.
The Society of Teachers of Family Medicine has partnered with NIDA to fund a yearlong training award of $10,000 (including $2,000 for a mentor stipend) to support the development of expertise in SUD through completion of a mentored experience and project focused on dissemination of SUD treatment that uses existing evidence-based research knowledge.
The goals of the NIDA-STFM Mentored Training Award is to:
- Promote and improve knowledge of evidence-based SUD treatment among health care providers
- Promote dissemination of substance use disorder research findings
- Promote the adoption of evidence-based approaches in medical settings
- Facilitate the academic growth and development of future leaders in SUD management
The award recipient will develop and execute a plan to increase his or her knowledge of SUD and SUD treatment and complete a project aimed at improving the dissemination and/or adoption of evidence-based SUD treatment knowledge.
This award cannot be used to conduct basic or clinical research studies or trials. Secondary data analysis may be completed, provided the project proposed is eligible for IRB exemption and has a dissemination/adoption focus.
This award is available to STFM-member residents or fellows at US residency programs. (They may join STFM in order to apply for the award). Awards are for projects conducted in the United States.
Applicants cannot have an NIH career development award.
Purpose of the Award
The purpose of this award is to:
- Provide the trainee with a mentored opportunity to learn about key areas of SUD and SUD treatment strategies through systematic literature review, attendance at conferences and workshops, and interaction with leading experts in the field.
- Provide the trainee with experience that eventually fosters interest in either a clinical career providing evidence-based management of SUD in medical settings or interest in securing an NIH career development or other grant award to pursue implementation and related research in the field of substance misuse and substance use disorder in subsequent years.
- Provide the trainee with education and experience in identifying evidence and developing strategies and resources that could be used in clinical practice or the dissemination and implementation of existing treatment strategies.
Applicants are encouraged to develop projects that address or improve upon current gaps in the dissemination of research findings or implementation/adoption of evidence-based treatment practices. The projects should be presented at the STFM Annual Spring Conference.
Applicants must submit the following information via a single PDF by email to Nicole Jacobs-Silvey:
A cover sheet that includes:
- Full name of applicant
- Applicant's mailing address and email address
- Name of residency or fellowship program
- Whom check should be made out and where it should be sent if funding is awarded
- Project title
- A training plan, project description, timeline for the award year, budget and budget justification, literature cited, and other support. The project description should include objectives, background information, and proposed activities. Funds may be used for the project/training/mentored activity, travel to STFM's Annual Spring Conference, and travel to the National Drug Abuse Treatment Clinical Trials Network Annual Meeting.
- A letter detailing any current and previous funding.
- The applicant’s and mentor’s current biosketches.
- A letter of support from a proposed mentor that includes a plan for regular in-person, phone, or video meetings; assistance with planning and execution of the project; and assistance with developing the presentation.
- A letter of support from applicant's program director.
Each application will be reviewed by experts involved and informed in dissemination of findings from the field of SUD. Each application will be judged primarily on the likelihood of producing dedicated, qualified clinicians and champions in the field of medicine and SUD as indicated by 1) the qualifications of the applicant, 2) the qualifications of the mentor, 3) the overall merit of the training plan and project, 4) the adequacy of the proposed budget to meet the objectives, and 5) the willingness of the program to provide the necessary support to complete the project as described.
Program Activities and Requirements
Progress and Final Report: The mentor and designated NIDA-STFM awardee are required to submit a 6-month narrative progress report and a final narrative report. The final report must include an accounting report using Generally Accepted Accounting Procedures showing the distribution of funds with a signature from an institutional official (e.g., accountant, grants manager).
STFM Annual Spring Conference: Awardees are required to present their work at the STFM Annual Spring Conference following the completion of the award. Presentations should acknowledge the support of NIDA-STFM.
NIDA CTN Meeting: Award recipients are expected to attend the NIDA Clinical Trials Network Annual Steering Committee Meeting. The meeting will take place March 23-24, 2017 in Bethesda, MD.
Publications: All materials (curriculum, etc.) resulting from work supported in part by the NIDA-STFM Award should be made available to the public through approved channels, such as national meetings and peer reviewed publications. Publications will acknowledge the support of NIDA and STFM. Two reprints of each publication should be forwarded to NIDA and STFM.
Follow Up: Recipients will be contacted annually by the Blending Initiative following completion of the funding year regarding career paths, ongoing dissemination or implementation activities, leadership in promoting the adoption of evidence-based practices in clinical settings, subsequent grants/contracts obtained, and publications. Recipients will be expected to supply information about their activities post-award.
Examples of activities include but are not limited to:
- Reviewing available curricula or training programs, identifying status of education on SUD diagnosis and treatment in various settings, and proposing and conducting activities to improve training
- Identifying best practices or effective strategies or models for the clinical management of SUD, and/or application of guidelines, and developing a plan for their implementation
- Developing materials that could be used for quality improvement or integration of an evidence-based approach or process in a medical setting and conducting activities for quality improvement or adoption
- Identifying potential partners and developing and implementing a plan for effective dissemination of research findings and products developed by NIDA or other federal agencies or professional associations within existing or newly developed communication channels
- Other activities consistent with the goals of the Blending Initiative to accelerate the dissemination of research findings and implementation or adoption of evidence-based SUD treatment in clinical practice
- Coursework to strengthen formal training in the management of substance use disorder
- Analysis of de-identified data from completed clinical trials such as those found on the NIDA Data Share website to inform dissemination or implementation efforts
- Analysis of de-identified data from electronic health records or registries such as the ACEP Clinical Emergency Data Registry to characterize availability of data on substance use or practice patterns, identify gaps in the provision of evidence-based practices, and/or identify needs for dissemination or implementation
Project duration can be for up to one year.
Email Mary Theobald
Patent Policy: The Mentor, the Awardee, and their respective institution(s) acknowledge that if a patentable invention or discovery is conceived, or conceived and reduced to practice by the Award during the term of the award year, NIDA and STFM must be apprised of the invention and the institution’s plans for protecting such invention under existing institutional patent policy. STFM will defer to institutional policies where they are in compliance with those of the Federal government. NIDA and STFM reserves the right where the institution has no patent policy, or policies not in compliance with those of the federal government, to claim rights and interests in the invention or discovery consistent with FAR Clause 52.227-11, Patent Rights- Ownership by the Contractor.